Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Andrea De La Cerda
Andrea De La Cerda leads Scorpion's strategy for the medical team and enjoys educating practice owners about digital marketing solutions designed to grow their businesses. Andrea brings more than 20 years of award-winning national and international marketing expertise to the Scorpion team. For more information about Scorpion, visit www.scorpion.co.